The ACR/CHEST ILD Guidelines in Practice: Register Now for This Informative Webinar

Search results for: hip OA

Never Give Up on a Patient

Catherine Kolonko | May 16, 2011

ACR President David Borenstein, MD, receives AF honor for his dedication to rheumatology

Drug Updates

Michele B. Kaufman, PharmD, BCGP | May 16, 2011

Information on New Approvals and Medication Safety

Rheum with a View

Richard S. Panush, MD | May 16, 2011

Panush’s perspectives on selections from the literature

Ethics Forum

Michele Meltzer, MD, MBE, C. Ronald MacKenzie, MD, and Elizabeth A. Kitsis, MD, MBE | May 16, 2011

What’s your ongoing obligation to care for patients who can’t pay?

New Research Shows Chondroitin Sulphate Reduces Cartilage Volume Loss, Bone Marrow Lesions

Sue Pondrom | May 13, 2011

However, conflicting data and small study size make it difficult to draw firm conclusions

The LUMINA Study

Graciela S. Alarcon, MD, MPH | April 13, 2011

Impact beyond lupus in U.S. Hispanics

Are We There Yet?

David Borenstein, MD | April 13, 2011

Advancing rheumatology through public relations

Trillions of SNPs Versus a Glass of Grappa

David S. Pisetsky, MD | April 13, 2011

Will personalized medicine make us healthier or just contribute to information overload?

Promoting Arthritis Research to Congress and Others

Staff | April 13, 2011

The ACR works to promote clinical and basic research in arthritis and musculoskeletal disease through a variety of channels, including advocacy, working directly with the National Institutes of Health (NIH), and through the work of the ACR Research and Education Foundation.

RheumPAC: Advance Rheumatology on Capital Hill

Staff | April 13, 2011

One way to succeed in our mission of advancing rheumatology is to increase the ACR’s presence on Capitol Hill through grassroots and direct lobbying. However, for the rheumatology subspecialty to be most effective we must use all tools available to us, including RheumPAC, the ACR’s nonpartisan political action committee. RheumPAC demonstrates to members of Congress that the rheumatology subspecialty is committed to political action, educating policy makers, and improving healthcare for our patients.